Loading company…
Mediark develops advanced chemical, biomaterial, and drug delivery technologies.
Mediark develops materials including metal-organic frameworks, zeolitic imidazole frameworks, and covalent organic frameworks for uses such as gas adsorption, catalysts, and sensors. It also develops customized materials and drug delivery platforms using hybrid nano- and microparticles, including mRNA technologies. The company is based in Cheongju, South Korea, and was founded in 2022. In January 2025, it raised venture funding led by JNP-AVENTURES Co., Ltd.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in